{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:49:55Z","timestamp":1792093795535,"version":"4.4.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11102-016-0783-5","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T06:59:38Z","timestamp":1487228378000},"page":"154-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Updates in outcomes of stereotactic radiation therapy in acromegaly"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1754-5619","authenticated-orcid":false,"given":"Monica Livia","family":"Gheorghiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"issue":"5","key":"783_CR1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","volume":"94","author":"S Melmed","year":"2009","unstructured":"Melmed S, Colao A, Barkan A et al (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94(5):1509\u20131517","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"783_CR2","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"783_CR3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.rpor.2014.09.004","volume":"21","author":"G Minniti","year":"2016","unstructured":"Minniti G, Clarke E, Scaringi C, Enrici RM (2016) Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas. Rep Pract Oncol Radiother 21(4):370\u2013378","journal-title":"Rep Pract Oncol Radiother"},{"issue":"2","key":"783_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijrobp.2009.07.1695","volume":"78","author":"PK Parhar","year":"2010","unstructured":"Parhar PK, Duckworth T, Shah P et al (2010) Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas. Int J Radiat Oncol Biol Phys 78(2):379\u2013384","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"783_CR5","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jcem.85.10.6870","volume":"85","author":"G Barrande","year":"2000","unstructured":"Barrande G, Pittino-Lungo M, Coste J et al (2000) Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 85(10):3779\u20133785","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"783_CR6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.2000.01095.x","volume":"53","author":"NR Biermasz","year":"2000","unstructured":"Biermasz NR, Dulken HV, Roelfsema F (2000) Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels. Clin Endocrinol 53(3):321\u2013327","journal-title":"Clin Endocrinol"},{"issue":"6","key":"783_CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","volume":"38","author":"M Brada","year":"1993","unstructured":"Brada M, Rajan B, Traish D et al (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 38(6):571\u2013578","journal-title":"Clin Endocrinol"},{"issue":"2","key":"783_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2265.2001.01294.x","volume":"55","author":"P Epaminonda","year":"2001","unstructured":"Epaminonda P, Porretti S, Cappiello V, Beck-Peccoz P, Faglia G, Arosio M (2001) Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly. Clin Endocrinol 55(2):183\u2013189","journal-title":"Clin Endocrinol"},{"issue":"4","key":"783_CR9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jc.2005-1616","volume":"91","author":"PJ Jenkins","year":"2006","unstructured":"Jenkins PJ, Bates P, Carson MN, Stewart PM, Wass JA (2006) Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 91(4):1239\u20131245","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"783_CR10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2265.2005.02199.x","volume":"62","author":"G Minniti","year":"2005","unstructured":"Minniti G, Jaffrain-Rea ML, Osti M et al (2005) The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol 62(2):210\u2013216","journal-title":"Clin Endocrinol"},{"issue":"5","key":"783_CR11","first-page":"2068","volume":"85","author":"JS Powell","year":"2000","unstructured":"Powell JS, Wardlaw SL, Post KD, Freda PU (2000) Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab 85(5):2068\u20132071","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"783_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11102-007-0002-5","volume":"10","author":"RS Jallad","year":"2007","unstructured":"Jallad RS, Musolino NR, Salgado LR, Bronstein MD (2007) Treatment of acromegaly: is there still a place for radiotherapy? Pituitary 10(1):53\u201359","journal-title":"Pituitary"},{"issue":"1","key":"783_CR13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.arcmed.2011.01.004","volume":"42","author":"B Gonzalez","year":"2011","unstructured":"Gonzalez B, Vargas G, Espinosa-de-los-Monteros AL, Sosa E, Mercado M (2011) Efficacy and safety of radiotherapy in acromegaly. Arch Med Res 42(1):48\u201352","journal-title":"Arch Med Res"},{"issue":"6","key":"783_CR14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/eje.0.1450717","volume":"145","author":"R Cozzi","year":"2001","unstructured":"Cozzi R, Barausse M, Asnaghi D, Dallabonzana D, Lodrini S, Attanasio R (2001) Failure of radiotherapy in acromegaly. Eur J Endocrinol 145(6):717\u2013726","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"783_CR15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","volume":"90","author":"G Minniti","year":"2005","unstructured":"Minniti G, Traish D, Ashley S, Gonsalves A, Brada M (2005) Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90(2):800\u2013804","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"783_CR16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0360-3016(99)00159-5","volume":"45","author":"M Brada","year":"1999","unstructured":"Brada M, Burchell L, Ashley S, Traish D (1999) The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys 45(3):693\u2013698","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"783_CR17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s11102-015-0653-6","volume":"18","author":"B Lecumberri","year":"2015","unstructured":"Lecumberri B, Estrada J, Garcia-Uria J et al (2015) Neurocognitive long-term impact of two-field conventional radiotherapy in adult patients with operated pituitary adenomas. Pituitary 18(6):782\u2013795","journal-title":"Pituitary"},{"issue":"1","key":"783_CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.2007.03169.x","volume":"69","author":"AA Klaauw van der","year":"2008","unstructured":"van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA (2008) Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin Endocrinol 69(1):123\u2013128","journal-title":"Clin Endocrinol"},{"issue":"4","key":"783_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-07-0358","volume":"157","author":"M Bex","year":"2007","unstructured":"Bex M, Abs R, T\u2019Sjoen G et al (2007) AcroBel\u2013the Belgian registry on acromegaly: a survey of the \u2018real-life\u2019 outcome in 418 acromegalic subjects. Eur J Endocrinol 157(4):399\u2013409","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"783_CR20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1530\/EJE-13-1022","volume":"171","author":"A Colao","year":"2014","unstructured":"Colao A, Vandeva S, Pivonello R et al (2014) Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy). Eur J Endocrinol 171(2):263\u2013273","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"783_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","volume":"151","author":"A Mestron","year":"2004","unstructured":"Mestron A, Webb SM, Astorga R et al (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish acromegaly registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151(4):439\u2013446","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"783_CR22","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","volume":"94","author":"M Sherlock","year":"2009","unstructured":"Sherlock M, Reulen RC, Alonso AA et al (2009) ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 94(11):4216\u20134223","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"783_CR23","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","volume":"89","author":"J Ayuk","year":"2004","unstructured":"Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89(4):1613\u20131617","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"783_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13014-016-0710-y","volume":"11","author":"G Minniti","year":"2016","unstructured":"Minniti G, Osti MF, Niyazi M (2016) Target delineation and optimal radiosurgical dose for pituitary tumors. Radiat Oncol 11(1):135","journal-title":"Radiat Oncol"},{"issue":"1","key":"783_CR25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11102-007-0004-3","volume":"10","author":"BK Roberts","year":"2007","unstructured":"Roberts BK, Ouyang DL, Lad SP et al (2007) Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary 10(1):19\u201325","journal-title":"Pituitary"},{"issue":"2","key":"783_CR26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-016-2105-1","volume":"128","author":"H Iwata","year":"2016","unstructured":"Iwata H, Sato K, Nomura R et al (2016) Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus. J Neurooncol 128(2):267\u2013275","journal-title":"J Neurooncol"},{"issue":"1","key":"783_CR27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2013.04.018","volume":"108","author":"T Gevaert","year":"2013","unstructured":"Gevaert T, Boussaer M, Engels B et al (2013) Evaluation of the clinical usefulness for using verification images during frameless radiosurgery. Radiother Oncol 108(1):114\u2013117","journal-title":"Radiother Oncol"},{"issue":"1","key":"783_CR28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jocn.2013.03.024","volume":"21","author":"HI Liao","year":"2014","unstructured":"Liao HI, Wang CC, Wei KC et al (2014) Fractionated stereotactic radiosurgery using the Novalis system for the management of pituitary adenomas close to the optic apparatus. J Clin Neurosci 21(1):111\u2013115","journal-title":"J Clin Neurosci"},{"issue":"1","key":"783_CR29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1042-3680(02)00031-1","volume":"14","author":"Z Petrovich","year":"2003","unstructured":"Petrovich Z, Jozsef G, Yu C, Apuzzo ML (2003) Radiotherapy and stereotactic radiosurgery for pituitary tumors. Neurosurg Clin N Am 14(1):147\u2013166","journal-title":"Neurosurg Clin N Am"},{"issue":"6","key":"783_CR30","doi-asserted-by":"crossref","first-page":"NP10","DOI":"10.1177\/1533034615607113","volume":"15","author":"P Puataweepong","year":"2016","unstructured":"Puataweepong P, Dhanachai M, Hansasuta A et al. The clinical outcome of hypofractionated stereotactic radiotherapy with CyberKnife robotic radiosurgery for perioptic pituitary adenoma. Technol Cancer Res Treat 2016;15(6):NP10\u2013NP15","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"783_CR31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11102-012-0384-x","volume":"16","author":"G Sesmilo","year":"2013","unstructured":"Sesmilo G, Gaztambide S, Venegas E et al (2013) Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish acromegaly registry (REA). Pituitary 16(1):115\u2013121","journal-title":"Pituitary"},{"issue":"3","key":"783_CR32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.14310\/horm.2002.1680","volume":"15","author":"O Karapanou","year":"2016","unstructured":"Karapanou O, Tzanela M, Christoforaki M et al (2016) Therapeutic trends and outcome of acromegaly: a single center experience over a 40-year period. Hormones 15(3):368\u2013376","journal-title":"Hormones"},{"issue":"Suppl 3","key":"783_CR33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3171\/jns.2000.93.supplement_3.0006","volume":"93","author":"N Zhang","year":"2000","unstructured":"Zhang N, Pan L, Wang EM, Dai JZ, Wang BJ, Cai PW (2000) Radiosurgery for growth hormone-producing pituitary adenomas. J Neurosurg 93(Suppl 3):6\u20139","journal-title":"J Neurosurg"},{"key":"783_CR34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-9966-28-36","volume":"28","author":"H Wan","year":"2009","unstructured":"Wan H, Chihiro O, Yuan S (2009) MASEP gamma knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases. J Exp Clin Cancer Res 28:36","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"783_CR35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-07-0189","volume":"157","author":"EO Vik-Mo","year":"2007","unstructured":"Vik-Mo EO, Oksnes M, Pedersen PH et al (2007) Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol 157(3):255\u2013263","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"783_CR36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2012.03.021","volume":"104","author":"G Sicignano","year":"2012","unstructured":"Sicignano G, Losa M, Del VA et al (2012) Dosimetric factors associated with pituitary function after gamma knife surgery (GKS) of pituitary adenomas. Radiother Oncol 104(1):119\u2013124","journal-title":"Radiother Oncol"},{"issue":"2","key":"783_CR37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3171\/2010.5.JNS091635","volume":"114","author":"JP Sheehan","year":"2011","unstructured":"Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML (2011) Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114(2):303\u2013309","journal-title":"J Neurosurg"},{"issue":"6","key":"783_CR38","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1365-2265.2009.03589.x","volume":"71","author":"CL Ronchi","year":"2009","unstructured":"Ronchi CL, Attanasio R, Verrua E et al (2009) Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study. Clin Endocrinol 71(6):846\u2013852","journal-title":"Clin Endocrinol"},{"issue":"Suppl","key":"783_CR39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3171\/2010.7.GKS10933","volume":"113","author":"TL Poon","year":"2010","unstructured":"Poon TL, Leung SC, Poon CY, Yu CP (2010) Predictors of outcome following Gamma Knife surgery for acromegaly. J Neurosurg 113(Suppl):149\u2013152","journal-title":"J Neurosurg"},{"issue":"5","key":"783_CR40","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3171\/jns.2007.106.5.833","volume":"106","author":"BE Pollock","year":"2007","unstructured":"Pollock BE, Jacob JT, Brown PD, Nippoldt TB (2007) Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 106(5):833\u2013838","journal-title":"J Neurosurg"},{"issue":"7","key":"783_CR41","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1210\/jc.2008-0135","volume":"93","author":"M Losa","year":"2008","unstructured":"Losa M, Gioia L, Picozzi P et al (2008) The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 93(7):2546\u20132552","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"783_CR42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11060-012-0862-z","volume":"109","author":"X Liu","year":"2012","unstructured":"Liu X, Kano H, Kondziolka D et al (2012) Gamma knife radiosurgery for clinically persistent acromegaly. J Neurooncol 109(1):71\u201379","journal-title":"J Neurooncol"},{"issue":"4","key":"783_CR43","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2013-3743","volume":"99","author":"CC Lee","year":"2014","unstructured":"Lee CC, Vance ML, Xu Z et al (2014) Stereotactic radiosurgery for acromegaly. J Clin Endocrinol Metab 99(4):1273\u20131281","journal-title":"J Clin Endocrinol Metab"},{"key":"783_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3171\/jns.2005.102.s_supplement.0119","volume":"102","author":"T Kobayashi","year":"2005","unstructured":"Kobayashi T, Mori Y, Uchiyama Y, Kida Y, Fujitani S (2005) Long-term results of gamma knife surgery for growth hormone-producing pituitary adenoma: is the disease difficult to cure? J Neurosurg 102:119\u2013123","journal-title":"J Neurosurg"},{"issue":"5","key":"783_CR45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2265.2006.02513.x","volume":"64","author":"J Jezkova","year":"2006","unstructured":"Jezkova J, Marek J, Hana V et al (2006) Gamma knife radiosurgery for acromegaly-long-term experience. Clin Endocrinol 64(5):588\u2013595.","journal-title":"Clin Endocrinol"},{"issue":"5","key":"783_CR46","first-page":"e12","volume":"14","author":"JA Jane Jr","year":"2003","unstructured":"Jane JA Jr, Vance ML, Woodburn CJ, Laws ER Jr (2003) Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. Neurosurg Focus 14(5):e12","journal-title":"Neurosurg Focus"},{"issue":"6","key":"783_CR47","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1227\/01.neu.0000333297.41813.3d","volume":"62","author":"J Jagannathan","year":"2008","unstructured":"Jagannathan J, Sheehan JP, Pouratian N, Laws ER Jr, Steiner L, Vance ML (2008) Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery. Neurosurgery 62(6):1262\u20131269","journal-title":"Neurosurgery"},{"issue":"Suppl 3","key":"783_CR48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3171\/jns.2000.93.supplement_3.0019","volume":"93","author":"M Izawa","year":"2000","unstructured":"Izawa M, Hayashi M, Nakaya K et al (2000) Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 93(Suppl 3):19\u201322","journal-title":"J Neurosurg"},{"issue":"3","key":"783_CR49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jocn.2009.05.040","volume":"17","author":"Y Iwai","year":"2010","unstructured":"Iwai Y, Yamanaka K, Yoshimura M, Kawasaki I, Yamagami K, Yoshioka K (2010) Gamma knife radiosurgery for growth hormone-producing adenomas. J Clin Neurosci 17(3):299\u2013304","journal-title":"J Clin Neurosci"},{"issue":"2","key":"783_CR50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11060-010-0172-2","volume":"98","author":"M Hayashi","year":"2010","unstructured":"Hayashi M, Chernov M, Tamura N et al (2010) Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: treatment concept and results in 89 cases. J Neurooncol 98(2):185\u2013194","journal-title":"J Neurooncol"},{"issue":"4","key":"783_CR51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-2005-837552","volume":"113","author":"B Gutt","year":"2005","unstructured":"Gutt B, Wowra B, Alexandrov R et al (2005) Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly. Exp Clin Endocrinol Diabetes 113(4):219\u2013224","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1\u20132","key":"783_CR52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.wneu.2013.01.127","volume":"82","author":"RA Grant","year":"2014","unstructured":"Grant RA, Whicker M, Lleva R, Knisely JP, Inzucchi SE, Chiang VL (2014) Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report. World Neurosurg 82(1\u20132):195\u2013201","journal-title":"World Neurosurg"},{"key":"783_CR53","doi-asserted-by":"crossref","first-page":"342034","DOI":"10.1155\/2012\/342034","volume":"2012","author":"A Franzin","year":"2012","unstructured":"Franzin A, Spatola G, Losa M, Picozzi P, Mortini P (2012) Results of gamma knife radiosurgery in acromegaly. Int J Endocrinol 2012:342034","journal-title":"Int J Endocrinol"},{"issue":"12","key":"783_CR54","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jocn.2011.03.023","volume":"18","author":"FM Erdur","year":"2011","unstructured":"Erdur FM, Kilic T, Peker S, Celik O, Kadioglu P (2011) Gammaknife radiosurgery in patients with acromegaly. J Clin Neurosci 18(12):1616\u20131620","journal-title":"J Clin Neurosci"},{"issue":"4","key":"783_CR55","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/cen.12938","volume":"84","author":"O Cohen-Inbar","year":"2016","unstructured":"Cohen-Inbar O, Ramesh A, Xu Z, Vance ML, Schlesinger D, Sheehan JP (2016) Gamma knife radiosurgery in patients with persistent acromegaly or Cushing\u2019s disease: long-term risk of hypopituitarism. Clin Endocrinol 84(4):524\u2013531","journal-title":"Clin Endocrinol"},{"issue":"8","key":"783_CR56","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2005-0311","volume":"90","author":"F Castinetti","year":"2005","unstructured":"Castinetti F, Taieb D, Kuhn JM et al (2005) Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 90(8):4483\u20134488","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"783_CR57","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2008-2772","volume":"94","author":"F Castinetti","year":"2009","unstructured":"Castinetti F, Nagai M, Morange I et al (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94(9):3400\u20133407","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"783_CR58","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/jc.2002-021663","volume":"88","author":"R Attanasio","year":"2003","unstructured":"Attanasio R, Epaminonda P, Motti E et al (2003) Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 88(7):3105\u20133112","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"783_CR59","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jfma.2012.01.020","volume":"112","author":"JL Yan","year":"2013","unstructured":"Yan JL, Chang CN, Chuang CC et al (2013) Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery. J Formos Med Assoc 112(7):416\u2013420","journal-title":"J Formos Med Assoc"},{"issue":"11","key":"783_CR60","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jocn.2012.11.026","volume":"20","author":"PJ Wilson","year":"2013","unstructured":"Wilson PJ, De-Loyde KJ, Williams JR, Smee RI (2013) Acromegaly: a single centre\u2019s experience of stereotactic radiosurgery and radiotherapy for growth hormone secreting pituitary tumours with the linear accelerator. J Clin Neurosci 20(11):1506\u20131513","journal-title":"J Clin Neurosci"},{"issue":"6","key":"783_CR61","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/cncr.22128","volume":"107","author":"J Voges","year":"2006","unstructured":"Voges J, Kocher M, Runge M et al (2006) Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 107(6):1355\u20131364","journal-title":"Cancer"},{"issue":"6","key":"783_CR62","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00066-014-0802-2","volume":"191","author":"JP Bostrom","year":"2015","unstructured":"Bostrom JP, Kinfe T, Meyer A et al (2015) Treatment of acromegaly patients with risk-adapted single or fractionated stereotactic high-precision radiotherapy: High local control and low toxicity in a pooled series. Strahlenther Onkol 191(6):477\u2013485","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"783_CR63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3340\/jkns.2009.45.3.157","volume":"45","author":"CB Cho","year":"2009","unstructured":"Cho CB, Park HK, Joo WI, Chough CK, Lee KJ, Rha HK (2009) Stereotactic Radiosurgery with the CyberKnife for Pituitary Adenomas. J Korean Neurosurg Soc 45(3):157\u2013163","journal-title":"J Korean Neurosurg Soc"},{"issue":"3","key":"783_CR64","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ijrobp.2014.06.068","volume":"90","author":"DA Wattson","year":"2014","unstructured":"Wattson DA, Tanguturi SK, Spiegel DY et al (2014) Outcomes of proton therapy for patients with functional pituitary adenomas. Int J Radiat Oncol Biol Phys 90(3):532\u2013539","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"783_CR65","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4158\/EP.13.7.726","volume":"13","author":"JH Petit","year":"2007","unstructured":"Petit JH, Biller BM, Coen JJ et al (2007) Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract 13(7):726\u2013734","journal-title":"Endocr Pract"},{"issue":"8","key":"783_CR66","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4158\/EP14574.OR","volume":"21","author":"AM Abu Dabrh","year":"2015","unstructured":"Abu Dabrh AM, Asi N, Farah WH et al (2015) Radiotherapy versus radiosurgery in treating patients with acromegaly: a systematic review and meta-analysis. Endocr Pract 21(8):943\u2013956","journal-title":"Endocr Pract"},{"issue":"3","key":"783_CR67","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11102-014-0578-5","volume":"18","author":"CC Lee","year":"2015","unstructured":"Lee CC, Vance ML, Lopes MB, Xu Z, Chen CJ, Sheehan J (2015) Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype. Pituitary 18(3):326\u2013334","journal-title":"Pituitary"},{"issue":"3","key":"783_CR68","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/jcem.85.3.6464","volume":"85","author":"AM Landolt","year":"2000","unstructured":"Landolt AM, Haller D, Lomax N et al (2000) Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 85(3):1287\u20131289","journal-title":"J Clin Endocrinol Metab"},{"key":"783_CR69","doi-asserted-by":"crossref","unstructured":"Losa M, Spatola G, Albano L et al. Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas. Endocrine 2016","DOI":"10.1007\/s12020-016-1081-8"},{"key":"783_CR70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3171\/sup.2006.105.7.31","volume":"105","author":"AM Landolt","year":"2006","unstructured":"Landolt AM, Lomax N, Scheib SG, Girard J (2006) Gamma Knife surgery after fractionated radiotherapy for acromegaly. J Neurosurg 105:31\u201336","journal-title":"J Neurosurg"},{"issue":"6","key":"783_CR71","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1530\/EJE-09-0493","volume":"161","author":"FM Swords","year":"2009","unstructured":"Swords FM, Monson JP, Besser GM et al (2009) Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy. Eur J Endocrinol 161(6):819\u2013828","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"783_CR72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0360-3016(89)90385-4","volume":"17","author":"JC Flickinger","year":"1989","unstructured":"Flickinger JC, Deutsch M, Lunsford LD (1989) Repeat megavoltage irradiation of pituitary and suprasellar tumors. Int J Radiat Oncol Biol Phys 17(1):171\u2013175","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"783_CR73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1227\/NEU.0b013e3182846e44","volume":"72","author":"Z Xu","year":"2013","unstructured":"Xu Z, Lee VM, Schlesinger D, Sheehan JP (2013) Hypopituitarism after stereotactic radiosurgery for pituitary adenomas. Neurosurgery 72(4):630\u2013637","journal-title":"Neurosurgery"},{"issue":"1","key":"783_CR74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3171\/2011.2.JNS10566","volume":"115","author":"P Taussky","year":"2011","unstructured":"Taussky P, Kalra R, Coppens J, Mohebali J, Jensen R, Couldwell WT (2011) Endocrinological outcome after pituitary transposition (hypophysopexy) and adjuvant radiotherapy for tumors involving the cavernous sinus. J Neurosurg 115(1):55\u201362","journal-title":"J Neurosurg"},{"issue":"3 suppl","key":"783_CR75","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijrobp.2009.07.1753","volume":"76","author":"C Mayo","year":"2010","unstructured":"Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J (2010) Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 76(3 suppl):28\u201335","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"783_CR76","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijrobp.2013.06.2047","volume":"87","author":"JA Leavitt","year":"2013","unstructured":"Leavitt JA, Stafford SL, Link MJ, Pollock BE (2013) Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 87(3):524\u2013527","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"783_CR77","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1530\/EJE-10-1105","volume":"164","author":"CL Ronchi","year":"2011","unstructured":"Ronchi CL, Verrua E, Ferrante E et al (2011) Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly. Eur J Endocrinol 164(5):675\u2013684","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"783_CR78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.radonc.2012.04.024","volume":"104","author":"MG Sattler","year":"2012","unstructured":"Sattler MG, van Beek AP, Wolffenbuttel BH et al (2012) The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone. Radiother Oncol 104(1):125\u2013130","journal-title":"Radiother Oncol"},{"issue":"12","key":"783_CR79","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","volume":"99","author":"M Mercado","year":"2014","unstructured":"Mercado M, Gonzalez B, Vargas G et al (2014) Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab 99(12):4438\u20134446","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"783_CR80","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","volume":"175","author":"J Dal","year":"2016","unstructured":"Dal J, Feldt-Rasmussen U, Andersen M et al (2016) Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175(3):181\u2013190","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"783_CR81","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.2014-3697","volume":"100","author":"NC Varsseveld van","year":"2015","unstructured":"van Varsseveld NC, van Bunderen CC, Ubachs DH et al (2015) Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch national registry of growth hormone treatment in adults. J Clin Endocrinol Metab 100(3):1104\u20131112","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"783_CR82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semradonc.2015.11.008","volume":"26","author":"SM Hiniker","year":"2016","unstructured":"Hiniker SM, Modlin LA, Choi CY et al (2016) Dose-response modeling of the visual pathway tolerance to single-fraction and hypofractionated stereotactic radiosurgery. Semin Radiat Oncol 26(2):97\u2013104","journal-title":"Semin Radiat Oncol"},{"key":"783_CR83","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clineuro.2016.09.009","volume":"150","author":"K Zhao","year":"2016","unstructured":"Zhao K, Liu X, Liu D et al (2016) Fractionated Gamma Knife surgery for giant pituitary adenomas. Clin Neurol Neurosurg 150:139\u2013142","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"783_CR84","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2004.09.058","volume":"62","author":"P Colin","year":"2005","unstructured":"Colin P, Jovenin N, Delemer B et al (2005) Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat Oncol Biol Phys 62(2):333\u2013341","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"783_CR85","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12020-015-0610-1","volume":"50","author":"AM Diallo","year":"2015","unstructured":"Diallo AM, Colin P, Litre CF et al (2015) Long-term results of fractionated stereotactic radiotherapy as third-line treatment in acromegaly. Endocrine 50(3):741\u2013748","journal-title":"Endocrine"},{"key":"783_CR86","unstructured":"Gheorghiu ML, Purice M, Poiana C, Coculescu M. Efficacy of pituitary radiotherapy on growth hormone (GH) secretion in patients with acromegaly. Abstract book for the American Association of Clinical Endocrinologists\u2019 21st Annual Meeting and Clinical Congress, May 23\u201327, Philadelphia, 2012, A152. 2012"},{"issue":"2","key":"783_CR87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3857\/roj.2016.01683","volume":"34","author":"MY Kim","year":"2016","unstructured":"Kim MY, Kim JH, Oh YK, Kim E (2016) Long-term outcomes of surgery and radiotherapy for secreting and non-secreting pituitary adenoma. Radiat Oncol J 34(2):121\u2013127","journal-title":"Radiat Oncol J"},{"issue":"4","key":"783_CR88","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2003.12.012","volume":"59","author":"S Milker-Zabel","year":"2004","unstructured":"Milker-Zabel S, Zabel A, Huber P, Schlegel W, Wannenmacher M, Debus J (2004) Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma. Int J Radiat Oncol Biol Phys 59(4):1088\u20131096","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"783_CR89","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2265.2006.02506.x","volume":"64","author":"G Minniti","year":"2006","unstructured":"Minniti G, Traish D, Ashley S, Gonsalves A, Brada M (2006) Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol 64(5):542\u2013548.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"783_CR90","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4158\/EP15830.OR","volume":"22","author":"H Patt","year":"2016","unstructured":"Patt H, Jalali R, Yerawar C et al (2016) High-precision conformal fractionated radiotherapy is effective in achieving remission in patients with acromegaly after failed transphenoidal surgery. Endocr Pract 22(2):162\u2013172","journal-title":"Endocr Pract"},{"issue":"4","key":"783_CR91","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/EJE-09-1045","volume":"162","author":"S Roug","year":"2010","unstructured":"Roug S, Rasmussen AK, Juhler M et al (2010) Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit. Eur J Endocrinol 162(4):685\u2013694","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"783_CR92","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/EJE-14-1117","volume":"172","author":"I Shimon","year":"2015","unstructured":"Shimon I, Jallad RS, Fleseriu M, Yedinak CG, Greenman Y, Bronstein MD (2015) Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors. Eur J Endocrinol 172(6):707\u2013713","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"783_CR93","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3171\/jns.1998.88.6.1002","volume":"88","author":"AM Landolt","year":"1998","unstructured":"Landolt AM, Haller D, Lomax N et al (1998) Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 88(6):1002\u20131008","journal-title":"J Neurosurg"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-016-0783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-016-0783-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-016-0783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T11:54:50Z","timestamp":1749988490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-016-0783-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1007\/s11102-016-0783-5","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}